Outcomes of the Japanese multicenter Viabahn trial of endovascular stent grafting for superficial femoral artery lesions

Stent grafting appears to be a safe and less invasive alternative to above-knee bypass surgery, providing 88% to 92% primary patency at 12 months in long, complex lesions.